Serum S100B, NSE, and GRIA1 levels as neurological biomarkers in lead exposure

Firat Oguz E., YILMAZ F. M., Tutkun E., Yilmaz O. H., Ercan M., Sezer S.

Turkish journal of medical sciences, vol.48, no.3, pp.449-454, 2018 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 48 Issue: 3
  • Publication Date: 2018
  • Doi Number: 10.3906/sag-1511-174
  • Journal Name: Turkish journal of medical sciences
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, TR DİZİN (ULAKBİM)
  • Page Numbers: pp.449-454
  • Ankara Yıldırım Beyazıt University Affiliated: Yes


Background/aim: The central nervous system is one of the major targets in lead exposure. Biomarkers for the diagnosis and follow-up of lead exposure have not been identified. In this study, serum S100B, neuron-specific enolase (NSE), and glutamate receptor 1 (GRIA1) levels were determined as possible biomarkers for lead neurotoxicity.